Perioperative anaphylaxis due to neuromuscular blocking agents occurred in roughly 58 per 100,000 administrations, with nearly 20% of cases associated with morbidity. Most patients recovered fully, ...
Baudax Bio, Inc. BXRX announced additional positive data from its phase II study of BX1000, which is used as a neuromuscular blockade (“NMB”) in patients undergoing elective surgery. The efficacy of ...
Follow us on Google for the latest stock newsFollow Seeking Alpha on Google for the latest stock news ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results